Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy
- 1 January 1996
- journal article
- clinical trial
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 4 (1) , 31-33
- https://doi.org/10.1007/bf01769872
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Role of pamidronate in the management of bone metastases from breast cancer: results of a non-comparative multicenter phase II trial. Aredia Multinational Cooperative Group.1994
- Treatment of bone metastases from breast cancer and myeloma with pamidronateEuropean Journal of Cancer and Clinical Oncology, 1991
- The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- PamidronateDrugs, 1991
- Etidronate disodium: a new therapy for hypercalcemia of malignancy. Proceedings of a symposium.1987
- Rationale for diphosphonate therapy in hypercalcemia of malignancyThe American Journal of Medicine, 1987
- Mineral homeostasis in neonates of streptozotocin-induced noninsulin-dependent diabetic rats and in their mothers during pregnancy and lactationBone, 1987
- Effect of diphosphonates on the synthesis of prostaglandins in cultured calvaria cellsCalcified Tissue International, 1981
- The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in cultureBiochemical Journal, 1978
- The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymesBiochimica et Biophysica Acta (BBA) - Enzymology, 1976